文献速递骨软组织肉瘤与黑色素瘤

lncRNA-SRLR通过PLOD2-FAK/STAT3轴促进骨肉瘤U2OS细胞侵袭转移

[Mechanism of lncRNA-SRLR induced invasion and metastasis in U2OS osteosarcoma cells].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2020-01-01

该研究在骨肉瘤U2OS细胞中过表达lncRNA-SRLR,发现其mRNA与PLOD2 mRNA表达显著升高,细胞迁移和侵袭能力增强,且PLOD2、p-FAK和p-STAT3蛋白表达上调;IL-6分泌无显著变化,lncRNA-SRLR主要定位于细胞核。结论提示lncRNA-SRLR可能通过激活PLOD2-FAK/STAT3信号轴促进骨肉瘤侵袭转移。

要点

  • 过表达lncRNA-SRLR可增强U2OS细胞迁移和侵袭能力。
  • lncRNA-SRLR上调PLOD2并激活FAK/STAT3通路磷酸化。
  • lncRNA-SRLR主要定位于细胞核,IL-6分泌未见显著改变。

核心结论

  • lncRNA-SRLR可能通过作用于PLOD2并激活FAK/STAT3通路诱导骨肉瘤U2OS细胞的侵袭和转移。

研究设计与样本

  • 体外细胞研究:用慢病毒空载对照(LV-NC)或lncRNA-SRLR过表达载体(LV-over/SRLR)转染U2OS细胞,并建立稳转株U2OS/NC和U2OS/SRLR。

主要发现

  • PLOD2 mRNA在U2OS/SRLR细胞中表达量为2.77±0.11,明显高于U2OS/NC细胞的1.00±0.04(P<0.01)。
  • 划痕实验和Transwell侵袭实验显示U2OS/SRLR细胞迁移和侵袭能力明显高于U2OS/NC细胞(P<0.05)。
  • ELISA显示U2OS/NC和U2OS/SRLR细胞上清液IL-6水平分别为125.38±11.22 pg/ml和119.97±13.43 pg/ml,差异无统计学意义(P>0.05)。
  • Western blot显示U2OS/SRLR细胞中PLOD2、p-FAK和p-STAT3蛋白相对表达量明显高于U2OS/NC细胞(P<0.01)。

关键数值与推荐

  • FISH检测显示lncRNA-SRLR主要定位于U2OS细胞核内。
  • 免疫荧光显示U2OS/SRLR细胞中PLOD2蛋白表达明显高于U2OS/NC细胞。

临床怎么用

  • 该研究为体外细胞机制探索,提示lncRNA-SRLR-PLOD2-FAK/STAT3轴可能作为骨肉瘤侵袭转移的潜在研究方向,尚需进一步临床与体内验证。

局限性

  • 研究仅采用U2OS骨肉瘤细胞系进行体外实验,未涉及体内模型或临床样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the potential mechanism of sorafenib resistance associated long non-coding RNA (lncRNA-SRLR) promoted invasion and metastasis in U2OS osteosarcoma cells. Methods: We transfected U2OS cells with negative control lentivirus (LV-NC) or lncRNA-SRLR overexpressed lentivirus (LV-over/SRLR) particles. LV-NC and LV-over/SRLR stable transfected cells (U20S/NC and U20S/SRLR) were selected by primary cell culture medium containing puromycin. The mRNA expressions of lncRNA-SRLR and procollagen-lysine, procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2) were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The effect of lncRNA-SRLR on the invasion of U2OS cells were determined by wound-healing assay and Transwell migration assay. The effect of SRLR on the interleukin-6 (IL-6) secretion of U2OS cells was evaluated by enzyme-linked immunosorbent assay (ELISA) analysis. The subcellular distribution of SRLR in U2OS cells was detected by fluorescence in situ hybridization (FISH) analysis.The expression of PLOD2 in cells was detected by immunofluorescence (IF). The expressions of PLOD2 and focal adhesion kinase (FAK)/signal transducer and activator of transcription 3 (STAT3) signal pathway related proteins in U2OS/NC and U2OS/SRLR cells were detected by western blotting. Results: qRT-PCR assay showed that mRNA expressions of lncRNA-SRLR and PLOD2 in U2OS/SRLR cells were (3 964.97±0.05) and (2.77±0.11), respectively, significantly higher than those in U2OS/NC cells (P<0.001 or P<0.01). The results of wound-healing and Transwell migration assay showed that over-expression of SRLR markedly promoted the invasion ability of U2OS cells (P<0.05). The result of ELISA analysis showed that the IL-6 secretions in U2OS/NC or U2OS/SRLR cells were (125.38±11.22) pg/ml or (119.97±13.43) pg/ml, without statistical significance (P>0.05). The subcellular distribution assay revealed that lncRNA-SRLR is predominately located in the nucleus. The result of IF showed that compared with U2OS/NC cells, the expression of PLOD2 was up-regulated in U2OS/SRLR cells. The result of western blotting showed that over-expression of SRLR significantly increased the expression levels of PLOD2, phosphorylation (p)-FAK and p-STAT3 in U2OS cells (P<0.01). Conclusion: lncRNA-SRLR promotes invasion and metastasis of osteosarcoma by activating PLOD2-FAK/STAT3 signal axis. 目的: 探讨肾癌索拉非尼耐药相关长链非编码RNA(lncRNA-SRLR)对骨肉瘤U2OS细胞侵袭和转移的机制。 方法: 应用慢病毒空载对照(LV-NC)和慢病毒lncRNA-SRLR过表达载体(LV-over/SRLR)转染U2OS细胞,并建立细胞稳转株U2OS/NC和U2OS/SRLR。应用实时荧光定量PCR(qRT-PCR)法检测lncRNA-SRLR和赖氨酸羟化酶(PLOD2)mRNA的相对表达量。采用transwell和划痕实验检测细胞迁移和侵袭能力。采用酶联免疫吸附法(ELISA)法检测白细胞介素6(IL-6)的表达情况。采用荧光原位杂交技术(FISH)检测lncRNA-SRLR细胞定位。采用免疫荧光法检测PLOD2蛋白的表达情况。采用Western blot法检测PLOD2和FAK/STAT3通路相关蛋白的表达情况。 结果: qRT-PCR检测结果显示,U2OS/NC和U2OS/SRLR细胞中lncRNA-SRLR mRNA的相对表达量分别为1.00±0.01和3 964.97±0.05,差异有统计学意义(P<0.001)。PLOD2 mRNA在U2OS/SRLR细胞中的表达量为2.77±0.11,明显高于对照U2OS/NC细胞(1.00±0.04,P<0.01)。划痕实验和侵袭实验均显示,U2OS/SRLR细胞的迁移和侵袭能力明显高于U20S/NC细胞(P<0.05)。ELISA法检测结果显示,U2OS/NC和U2OS/SRLR细胞上清液中IL-6的表达水平分别为(125.38±11.22)pg/ml和(119.97±13.43)pg/ml,差异无统计学意义(P>0.05)。免疫荧光检测结果显示,U2OS/SRLR细胞中PLOD2蛋白的表达明显高于U2OS/NC细胞。Western blot法检测结果显示,U2OS/SRLR细胞中PLOD2、p-FAK和p-STAT3等蛋白的相对表达量明显高于U2OS/NC细胞,差异有统计学意义(P<0.01)。 结论: lncRNA-SRLR可能通过作用于PLOD2,激活FAK/STAT3通路诱导了骨肉瘤U2OS细胞的侵袭和转移。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cao F, Kang XH, Wang DF, et al. [Mechanism of lncRNA-SRLR induced invasion and metastasis in U2OS osteosarcoma cells]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 33342156. doi:10.3760/cma.j.cn112152-20190404-00216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。